Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
Ralph A. DeFronzo(The University of Texas at San Antonio Health Science Center), Steven C. Griffen(Io Therapeutics (United States)), Sreeneeranj Kasichayanula(Gilead Sciences (United States)), Marcus Hompesch(AmeriCorps), Ying Hong(Nanjing Tech University), David W. Boulton(AstraZeneca (Poland)), Linda Morrow(AmeriCorps), Frank LaCreta(Fox Chase Cancer Center), Bruce R. Leslie(Bristol-Myers Squibb (Germany)), Xiaoni Liu(Bristol-Myers Squibb (Germany)), Agatha Ching(Bristol-Myers Squibb (Germany)), Marc Pfister(University Children’s Hospital Basel)
Cited by 289
Related Papers
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
|Journal of Clinical Investigation|2009|1.7k
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
|Diabetologia|2010|877
Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY
|Endocrine Practice|2016|875
Pathogenesis of Insulin Resistance in Skeletal Muscle
|Journal of Biomedicine and Biotechnology|2010|653